SAN DIEGO—Ambry Genetics and RainDance Technologies recently announced their partnership that pairs Ambry's genetic testing and next-generation sequencing services with RDT 1000, RainDance's microdroplet PCR-based solution. According to the companies, the partnership will enable researchers to either greatly reduce study time, or to improve study quality by running more samples in the same time within the same experimental budget. Ambry said it may add two new RainDance applications, Methyl-Seq and Ultra-Deep Resequencing, in the second half of 2010. Financial details were not released.